A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM1L | Absent in melanoma 1-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APBB3 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOLD1 | Apolipoprotein L domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
ARHGAP28 | Rho GTPase activating protein 28 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ASB9 | Ankyrin repeat and SOCS box containing 9 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ATF7IP2 | Activating transcription factor 7 interacting protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AUNIP | Aurora kinase A and ninein interacting protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | Predicted intracellular proteins
| | | | | Tissue enhanced |
BIRC7 | Baculoviral IAP repeat containing 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BNC2 | Basonuclin 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C11orf63 | Chromosome 11 open reading frame 63 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C16orf46 | Chromosome 16 open reading frame 46 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C16orf93 | Chromosome 16 open reading frame 93 | Predicted intracellular proteins
| | | | | Tissue enhanced |